1Cherniack NS. New mechanisms for the cardiovascular effects of sleep apnea. Am J Med,2000,109(7) :592-594.
2Nieto FJ, Young TB, Lind BK, et al. Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study., JAMA,2000,283(14) :1829-1236.
3Spector A. Review : Oxidative stress and disease. J Ocul Phamacol Ther,2000,16(2): 193-201.
4Christou K, Markoulis N, Moulas AN, et al. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath, 2003,7 (3): 105-110.
6Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med,2000,162(2 pt 1):566-570.
7Schulz R,Schmidt D, Blum A,et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnea : response to CPAP therapy. Throax,2000,55(12) :1046-1051.
8Schulz R, Seeger W, Grimminger F, et al. Serum nitrite/nitrate levels in obstructive sleep apnea. Am J Respir Crit Care Med,2000,164(10 pt 1):1997-1998.
9Lavie L,Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep,2004,27(1) :123-128.
10Ozturk L, Mansour B, Yuksel M, et al. Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta, 2003,332 (1-2): 83-88.
4Carlson J,Hedner J,Pettersson A.Increased plasma concentration ofADMA a naturally occurring nitric oxide synthesis inhibitor in OSA pa-tients[J].Am J Respir Crit Care Med,1997,155:A869.
5Cherniack N S.New mechanisms for the cardiovascular effects ofsleep apnea[J].Am J Med,2000,109(7):592-594.
6Spector A.Review:Oxidative stress and disease[J].Ocul PhamacolTher,2000,16(2):193-201.
7Dyugovskaya L,Lavie P,Lavie L.Increased adhesion molecules ex-pression and production of reactive oxygen species in leukocytes ofsleep apnea patients[J].Am J Respir Crit care Med,2002,165(7):934-939.
8Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996, 49:1304-1313.
9Kalousova M, Zima T, Tesar V, et al. Relationship between advanced glycoxidation end products, inflammatory markers/acute- phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl, 2003, 84 :S62-S64.
10Liu SX, Hou FF, Guo Z J, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vase Biol, 2006, 26: 1156-1162.
